UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials

Head & neck, 2016-04, Vol.38 (4), p.620-627

2016

Link zum Volltext

Verfügbarkeit prüfen

P1158: REAL‐WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND TREATMENT OUTCOMES OF PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) BY LINE OF THERAPY (LOT)

HemaSphere, 2023-08, Vol.7 (S3), p.e7626551-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P1695: REAL‐WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH R‐GEMOX IN THE RELAPSED/REFRACTORY SETTING

HemaSphere, 2023-08, Vol.7 (S3), p.e7912542-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy

Cancer medicine (Malden, MA), 2024-04, Vol.13 (7), p.e7173-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

P1144: PHASE 2 WAVELINE‐004 STUDY: ZILOVERTAMAB VEDOTIN (MK‐2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

HemaSphere, 2023-08, Vol.7 (S3), p.e03345ef-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

KEYNOTE B68: Open-label phase 2 study of the efficacy and safety of pembrolizumab administered every six weeks in patients with relapsed or refractory classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS7585-TPS7585

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data

Blood, 2022-11, Vol.140 (Supplement 1), p.5075-5076

2022

Link zum Volltext

Verfügbarkeit prüfen

Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.7920-7921

2022

Link zum Volltext

Verfügbarkeit prüfen

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

Blood, 2023-09, Vol.142 (10), p.878

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy

Blood, 2021-11, Vol.138 (Supplement 1), p.3924-3924

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of pembrolizumab every six weeks in relapsed/refractory classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma: The phase 2 KEYNOTE-B68 trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7517-7517

2023

Link zum Volltext

Verfügbarkeit prüfen

Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7531-7531

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Dose Escalation and Cohort Expansion Study of the Anti-ROR1 Antibody-Drug Conjugate Zilovertamab Vedotin (MK-2140) for the Treatment of Non-Hodgkin Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.528-528

2021

Link zum Volltext

Verfügbarkeit prüfen

Five-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)

Blood, 2021-11, Vol.138 (Supplement 1), p.1366-1366

2021

Link zum Volltext

Verfügbarkeit prüfen

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Blood, 2021-11, Vol.138 (Supplement 1), p.306-306

2021

Link zum Volltext

Verfügbarkeit prüfen

Accelerated fraction radiotherapy with concomitant capecitabine as neoadjuvant therapy of borderline resectable pancreatic cancer

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.329-329

2012

Link zum Volltext

Verfügbarkeit prüfen

Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer

Gastrointestinal cancer research, 2014-01, Vol.7 (1), p.15-22

2014

Link zum Volltext

Verfügbarkeit prüfen

Endometrial hormone receptors in women with dysfunctional uterine bleeding

Archives of gynecology and obstetrics, 2005-06, Vol.272 (1), p.17-22

2005

Link zum Volltext

Verfügbarkeit prüfen

A dependency annotation scheme for Bangla treebank

Language Resources and Evaluation, 2014-09, Vol.48 (3), p.443-477

2014

Link zum Volltext

Verfügbarkeit prüfen

Molybdenum(VI), (V) and (IV) complexes with chiral benzoin thiosemicarbazone

Transition metal chemistry (Weinheim), 2001-08, Vol.26 (4-5), p.557

2001

Link zum Volltext

Verfügbarkeit prüfen

SYNTHESIS AND CHARACTERIZATION OF MANGANESE(IV) COMPLEXES DERIVED FROM THE DIRECT REACTION OF MANGANESE(II) ACETATE TETRAHYDRATE WITH OXALOYLDIHYDRAZIDE AND 2-HYDROXY-1-NAPHTHALDEHYDE

Synthesis and reactivity in inorganic and metal-organic chemistry, 2002-11, Vol.32 (1), p.81-96

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials

P1158: REAL‐WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND TREATMENT OUTCOMES OF PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) BY LINE OF THERAPY (LOT)

P1695: REAL‐WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH R‐GEMOX IN THE RELAPSED/REFRACTORY SETTING

Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy

P1144: PHASE 2 WAVELINE‐004 STUDY: ZILOVERTAMAB VEDOTIN (MK‐2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

KEYNOTE B68: Open-label phase 2 study of the efficacy and safety of pembrolizumab administered every six weeks in patients with relapsed or refractory classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma

Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data

Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy

Efficacy and safety of pembrolizumab every six weeks in relapsed/refractory classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma: The phase 2 KEYNOTE-B68 trial

Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study

Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

Phase 1 Dose Escalation and Cohort Expansion Study of the Anti-ROR1 Antibody-Drug Conjugate Zilovertamab Vedotin (MK-2140) for the Treatment of Non-Hodgkin Lymphoma

Five-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Accelerated fraction radiotherapy with concomitant capecitabine as neoadjuvant therapy of borderline resectable pancreatic cancer

Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer

Endometrial hormone receptors in women with dysfunctional uterine bleeding

A dependency annotation scheme for Bangla treebank

Molybdenum(VI), (V) and (IV) complexes with chiral benzoin thiosemicarbazone

SYNTHESIS AND CHARACTERIZATION OF MANGANESE(IV) COMPLEXES DERIVED FROM THE DIRECT REACTION OF MANGANESE(II) ACETATE TETRAHYDRATE WITH OXALOYLDIHYDRAZIDE AND 2-HYDROXY-1-NAPHTHALDEHYDE

Suchergebnisse filtern